ghit fund
GHIT Awards Seven New Grants Amounting To US$15.3 Million
Research in the neglected tropical diseases of dengue, malaria and Chagas disease receive a US$15.3 million boost in funding from GHIT.
US$12 Million In Grants Awarded For Neglected Diseases
Japan's Global Health Initiative Technology Fund has committed US$12 million in grants for neglected diseases and a potential tuberculosis vaccine.
Takeda, MMV Partner To Study Anti-Malarial Compounds
Takeda Pharma will collaborate with Medicines for Malaria Venture to study two new anti-malarial compounds.